COMPANY

Ampersand Biomedicines

HQ: Watertown, MA source · ampersand.bio ↗ · New England

Location: Watertown, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Series B · $65M · announced Mar 19, 2025 Company release ↗
Source quote
- Mar 19, 2025 · Company release ↗
  “– Ampersand Biomedicines … a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced it has secured $65 million in Series B funding from investors including Ampersand’s founder, Flagship Pioneering, Eli Lilly & Comp”

Raises announced in these releases: $65M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Mar 19, 2025 Raise Private equity round — Series B: $65M (total, as published), announced Mar 19, 2025. Source: company's own press page. source ↗
Mar 19, 2025 Raise Series B · $65M source ↗
Nov 20, 2024 Partnership Partnership / licensing announced Nov 20, 2024. Source: company's own press page. source ↗

Raised: $65.0M. Last 2 years.

Mar 19, 2025 Private equity round — Series B: $65M (total, as published), announced Mar 19, 2025. Source: company's own press page. source ↗
Nov 20, 2024 Partnership / licensing announced Nov 20, 2024. Source: company's own press page. source ↗